Home/Guardant Health/Derek Bertocci
DB

Derek Bertocci

Chief Financial Officer

Guardant Health

Therapeutic Areas

Guardant Health Pipeline

DrugIndicationPhase
Shield (ECLIPSE Study)Colorectal Cancer ScreeningFDA Approved
SHIELD LUNG StudyLung Cancer ScreeningRegistrational
ALMANAC StudyMulti-Cancer Early DetectionResearch
Guardant Infinity Biomarker DiscoveryVarious Solid TumorsDevelopment/Commercial